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Abstract
Literature suggests that young adult prescription opioid misusers who are using alternate routes of 
administration (e.g., snorting, injecting) may be engaging in sexual and non-sexual HIV risk 
behaviors. This study examines demographics, substance use, sexual risk behavior, and health and 
social problems associated with alternate routes of administration of prescription opioids among a 
sample of young adult prescription opioid misusers. Data are drawn from baseline assessments 
from a behavioral intervention trial. Eligible participants were ages 18–39, and reported recent 
(past 90 days) heterosexual sex, and recent and regular substance use and attendance at large 
recognized local nightclubs. The analyses include 446 racially/ethnically diverse participants. In 
bivariate regression models, compared to those who did not, participants reporting alternate routes 
of administration (n=209) were more likely to be White (p<0.025) and report group sex 
participation history (p=0.002), sex with an injection drug user (p=0.003), sexual victimization 
history (p=0.003), and severe mental distress (p<0.000). White race, group sex participation 
history, and severe mental distress remained significant in the multivariate model. Alternate routes 
of administration of prescription opioids are associated with sexual HIV transmission risk 
behaviors. Early prevention and intervention efforts that address sexual and non-sexual HIV risk 
behaviors are warranted.
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Misuse prescription opioids has become a nationwide problem, especially for young adults 
(SAMHSA 2011, SAMHSA 2012). Significant increases in lifetime prescription opioid 
misuse have been observed among 18–25 year-olds between 2002 and 2010 (SAMHSA 
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2011). Although a modest decline in use among 18–25 year olds was noted in 2011 
(SAMHSA 2012), prescription opioids remain the second most commonly used drug in the 
past month after marijuana among this age group. At the same time, data show net declines 
in cocaine use among young adults from 2002 to 2010 (SAMHSA 2012), suggesting that the 
misuse of prescription drugs may be replacing other types of substance use among this 
cohort.
The misuse of prescription opioids among young people is associated with several health 
and social problems, including mental distress, victimization, and homelessness (Schrager et 
al. 2014, Mackesy-Amiti, Donenberg, and Ouellet 2015, Jessell et al. 2015). The use of 
alternate routes of administration of prescription opioids, including snorting, smoking, or 
injecting, may result in increased vulnerability, as the effects of the drug are intensified and 
the risk of addiction is elevated (Compton and Volkow 2006). Moreover, injecting 
prescription opioids puts young adults at greater risk for acquiring HIV or Hepatitis C 
infection because of prevalent needle risk behaviors (Mateu-Gelabert et al. 2015, Surratt, 
Kurtz, and Cicero 2011, O’Grady, Kurtz, and Surratt 2012, Johnson et al. 2013).
Several studies have found elevated sexual risk behaviors among people who inject drugs, 
including, risky injection practices, having an injecting sex partner, and having condomless 
sex with multiple sex partners (Surratt, Kurtz, and Cicero 2011, Meade, McDonald, and 
Weiss 2009; Miller et al. 2002; Centers for Disease Control and Prevention 2012). Yet, 
limited information has been published regarding sexual HIV transmission risk behaviors 
among young adults engaging in alternate routes of administration of prescription opioids. 
Emerging data suggest that prescription opioid misusers, including those who report 
alternate routes of administration of opioids, are engaging in sexual risk behavior, including 
condomless vaginal and anal sex and group sex (Mateu-Gelabert et al. 2015, Buttram and 
Kurtz 2015, Johnson et al. 2013). In addition, in-depth research conducted among young 
adult prescription opioid misusers shows that both men and women report a variety of sexual 
behaviors and risks, including increased sexual encounters, implicit and explicit exchanges 
of drugs and sex, sexual victimization, and casual sex with other prescription opioid 
misusers (Johnson et al. 2013, Mateu-Gelabert et al. 2015, Jessell et al. 2015).
Although research suggests a link between alternate routes of administration of prescription 
opioids and sexual HIV transmission risk behaviors among young adults, no study has 
examined this phenomenon among a large sample. The current study examines the 
relationship between alternate routes of administration of prescription opioids and health and 
social problems related to sexual HIV transmission risk among a sample of young adult 
prescription opioid misusers. Specifically, we tested the hypothesis that young adults who 
report alternate routes of administration of prescription opioids will also report elevated 
sexual HIV transmission risk behaviors.
Methods
Site
Miami-Dade County, Florida, is a diverse community of more than 2.6 million people with 
large numbers of foreign-born residents (51%) (U.S. Census Bureau 2010). Hispanics 
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(65.0%) are the largest ethnic group, with African Americans/Blacks representing 18.9%, 
and non-Hispanic Whites 15.4% of the county population. The Miami metropolitan area 
reports the highest HIV and AIDS incidence rates in the U.S. (CDC 2009). At the same 
time, Miami has become a national and international destination for partying, sexual 
tourism, and club drug use. It has been noted that South Beach has also become an East 
Coast center for club culture, setting substance use trends that are emulated and replicated 
elsewhere in the United States (Kurtz et al. 2013).
Sample
Data are drawn from a behavioral substance use and sexual risk reduction intervention trial 
that was designed for young adults in the club drug scene. A total of 498 participants 
completed baseline comprehensive health and social risk assessments between September 
2011 and November 2014. The present analyses are based on a sub-sample of these 
participants who report past 90 day prescription opioid misuse (n=446; 89.6% of the total 
sample). To be eligible for the trial, participants reported: 1) sex with a partner of the 
opposite gender during the past 90 days; 2) being between the ages of 18–39; 3) use one or 
more club drugs (defined as powder cocaine, ecstasy, GHB, methamphetamine, ketamine, 
and LSD) at least three times during the past 90 days; 4) non-medical use of one or more 
psychoactive prescription medications at least once during the past 90 days; and 5) regular 
attendance at large recognized local nightclubs.
Participants were recruited through respondent-driven sampling (RDS) (Heckathorn, 1997), 
a form of chain referral sampling, which has been shown to reduce sources of respondent 
bias (such as age, race/ethnicity, gender, and drug of choice) as successive branches or 
waves of respondents are enrolled and then solicited for additional contacts (Heckathorn, 
1997, 2002). In this study, initial respondents (“seeds”) were recruited through outreach at 
local nightclubs and existing contacts in the club culture. Each seed and subsequent study 
participant was provided with recruitment coupons to give to other club drug users in their 
social network, with the understanding that they would earn $50 for the recruitment of each 
additional eligible respondent. Each respondent/recruiter was limited to five coupons to 
prevent a few participants with large social networks from biasing the overall sample toward 
those with similar demographic and drug using profiles (homophily) (Heckathorn 1997).
Informed consent was obtained from all participants prior to study participation. As per the 
study design, participants were randomized to complete baseline assessments via a 
Computer-Assisted Personal Interview (CAPI) or an Audio-Assisted Computer Self 
Interview (ACASI). Participants were given a $50 stipend for their time and travel expenses 
following the interview. This study was approved by the Nova Southeastern University 
Institutional Review Board.
Measures
Demographic measures included age, gender, race/ethnicity, and education. Age was 
dichotomized into “young” (i.e., 18–24) versus not. Race/ethnicity was assessed by asking 
participants if they were Hispanic or Latino, followed by asking them what race/ethnicity 
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they consider themselves to be. Years of education was assessed with the question, “What is 
the highest grade or year you completed in school?”
The Global Appraisal of Individual Needs (GAIN, v. 5.4) (Dennis 2006) was the primary 
component of the standardized baseline assessments. This instrument has several core 
sections (e.g., background, substance use, physical health, sexual risk behaviors, mental 
health, and victimization), with each containing questions on the recency of problems, 
breadth of symptoms, and recent (past 90 day) and lifetime frequencies in days or times. 
Substance use measures included past 90 day frequencies of use of a variety of substances 
including alcohol, marijuana, cocaine (powder and crack), ecstasy, LSD, hallucinogens (e.g., 
mushrooms; PCP; ketamine), methamphetamine, GHB, heroin and the non-medical misuse 
of prescription sedatives (e.g., Xanax), opioids (e.g., Percocet), stimulants (e.g., Adderall), 
and antipsychotics (e.g., Seroquel). Participants were also asked whether they had injected 
drugs during the past 90 days. For analysis, substance use and drug injection measures were 
dichotomized into “yes” and “no”. Participants who reported prescription opioid misuse 
were also asked to describe all routes of opioid administration during the past 90 days. All 
routes besides swallowing a whole pill or liquid were categorized as an alternate route of 
administration, which included swallowing a crushed pill, placing it under the tongue, 
placing it inside the vagina and/or anus, smoking, snorting, injecting, and parachuting 
(swallowing a crushed pill inside of a piece of paper tissue or toilet paper).
Sexual behavior questions included counts of past 90 day condomless vaginal intercourse 
and condomless anal intercourse. Group sex participation was assessed by asking 
participants if they had ever participated in group sex (defined as three or more people, 
including the participant). Additional questions asked, if during the past 12 months, a 
participant had bought sex, (i.e., “use money or drugs to purchase or get sex”), traded sex 
(i.e., “have sex to get drugs, gifts, or money”), or had sex with an injection drug user. High 
risk sex was defined as recent condomless vaginal and/or anal intercourse in the context of a 
non-monogamous relationship or with a non-primary/casual partner during the past 90 days. 
Finally, being high for sex was assessed with the question, “How often in the past 90 days 
were you ‘high’ on either alcohol or drugs when you were having sex with another person?” 
Responses were based on a five point scale ranging from “never” to “almost all the time.” 
For analysis, this measure was dichotomized into being “high for sex half the time or more” 
versus not.
Victimization histories were assessed by affirmative responses to the following events: being 
attacked with a weapon or being beaten so as to cause bruises, cuts, or broken bones 
(physical) or being forced to participate in sexual acts against one’s will (sexual). The GAIN 
includes the General Mental Distress Scale (GMDS), which includes past year symptoms of 
somatization (four items, e.g., sleep trouble; shortness of breath or lump in the throat), 
depression (nine items, e.g., feeling sad, lonely or hopeless; feeling tired or having no 
energy), and anxiety (ten items, e.g., feeling nervous, anxious or tense; unable to control 
worries). The GMDS is further reducible to classifications indicating clinical significance: 
subclinical, moderate, and severe (Dennis 2006). This scale was dichotomized into “severe” 
and “not severe” for analysis. Substance dependence was assessed by the endorsement of 
three or more of seven Diagnostic and Statistical Manual of Mental Disorders, 4th edition 
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(DSM-IV) symptoms during the past 90 days (e.g., needing more drug to get the same 
effect; experience withdrawal symptoms; being unable to quit or cut down). Participants 
were also asked whether they had ever been arrested, which was dichotomized into “yes” 
and “no” for analysis.
Data Analyses
All analyses were conducted using IBM SPSS Statistics version 21. Descriptive statistics for 
the study sample were calculated for the variables of interest. Bivariate logistic regression 
models were constructed to examine alternate routes of administration of prescription 
opioids among participants who reported recent prescription opioid misuse. Variables in the 
bivariate models included demographics, HIV/STI risk behavior, mental health and 
victimization. Those measures that exhibited significant associations in the bivariate models 
were included in a multivariate logistic regression model.
Results
As shown in Table 1, the study includes 446 young adult prescription opioid misusers. The 
mean age is 25.14 (SD=5.395). The racially/ethnically diverse sample was 64.1% Hispanic, 
21.7% African American/Black, 11.2% White and 2.9% “other” race/ethnicity. Nearly half 
(45.3%) of participants were female. Twelve or more years of education was reported by 
85.0% of participants.
Most participants reported the recent use of alcohol (99.8%%), marijuana (95.3%), cocaine, 
(93.7%), and ecstasy (98.2%). Additional substances used include crack cocaine (28.5%), 
LSD (50.2%), hallucinogens (58.3%), methamphetamine (25.6%), GHB (17.3%), and heroin 
(23.1%). Participants also reported the misuse of additional prescription drugs including 
stimulants (49.8%), sedatives (93.5%), antidepressants (26.9%), and antipsychotics (29.6%). 
Injection drug use during the past 90 days (14.8%;) was also reported. An alternate route of 
administration of a prescription opioid was reported by 35.2%.
During the past 90 days, a majority of participants reported condomless vaginal intercourse 
(90.6%), and 40.1% reported condomless anal intercourse. Group sex participation was 
reported by 41.0% of the sample. Smaller numbers of participants engaged in the past year 
sexual risk behaviors of buying sex (11.0%), trading/selling sex (14.3%), and sex with an 
injection drug user (12.6%;). However, a majority of the sample reported recent high risk sex 
(69.1%; n=308) and being high for sex half the time or more (78.5%).
Physical abuse history was reported by 43.3% and sexual abuse history was reported by 
19.1% of participants. More than half (52.0%) of participants reported past year severe 
mental distress. A majority of the sample reported recent substance dependence (58.5%) and 
arrest history (64.8%).
Bivariate logistic regression models are shown in Table 2. Age and gender were not 
associated with alternate routes of administration of prescription opioids. Employing White 
as a reference category, all other race/ethnicity categories were associated with lower odds 
of using alternate routes of administration of opioids, which included Hispanic (OR=0.364; 
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95% CI=0.197, 0.674; P=0.001), African American/Black (OR=0.207; 95% CI=0.099, 
0.432; P<0.000), and other race/ethnicity (OR=0.200; 95% CI=0.049, 0.818; P=0.025). Two 
sexual HIV transmission risk behaviors were associated with higher odds of using alternate 
routes of administration including group sex participation (OR=1.876; 95% CI=1.264, 
2.784; P=0.002), and sex with an injection drug user (OR=2.389; 95% CI=1.356, 4.209; 
P=0.003). Sexual abuse history (OR=2.089; 95% CI=1.294, 3.375; P=0.003) and past year 
severe mental distress (OR=2.087; 95% CI=1.400, 3.111; P<0.000) were also associated 
with higher odds of using alternate routes of administration.
Significant associations from the bivariate logistic regression models were combined into a 
multivariate model, shown in Table 3. Employing White as a reference category, all other 
race/ethnicity categories were associated with lower odds of using alternate routes of 
administration of opioids, which included Hispanic (OR=0.378; 95% CI=0.198, 0.722; 
P=0.003), African American/Black (OR=0.211; 95% CI=0.098, 0.454; P<0.000), and other 
race/ethnicity (OR=0.161; 95% CI=0.037, 0.699; P=0.015). Group sex participation history 
(OR=1.641; 95% CI=1.076, 2.503; P=0.021) and past year severe mental distress 
(OR=1.799; 95% CI=1.161, 2.789; P=0.009) also remained significant in the model, with 
higher odds of alternate routes of administration.
Discussion
This is one of the first studies to examine alternate routes of administration of prescription 
opioids and associated sexual HIV transmission risk behaviors and other health and social 
problems among a sample of young adults. The total number of participants completing 
baseline assessments was 498, of which nearly 90% (N=446) reported recent prescription 
opioid misuse and were included in the present analyses. This finding suggests that even 
though Florida enacted a prescription drug monitoring program and regulated opioid 
dispensaries, or “pill mills” in 2010 and 2011 (Surratt et al. 2014, Rutkow et al. 2015), the 
majority of young adults in the sample were recruited after 2011 and maintained access to 
and continued misusing prescription opioids. In addition, more than 35% of recent 
prescription opioid misusers reported alternate routes of administration, which is worrying 
because HIV and hepatitis C are potentially transmissible through the sharing of injection 
and snorting equipment (Aaron et al. 2008, MacDonald, Crofts, and Kaldor 1996). In 
addition, participants engaging in alternate routes of administration may be more vulnerable 
to addiction or overdose (Young, Havens, and Leukefeld 2010, Hall et al. 2008, Surratt, 
Kurtz, and Cicero 2011).
The findings related to sexual HIV transmission risk behaviors in the multivariate model 
confirm our hypothesis. Alternate routes of administration were associated with group sex 
participation history. Group sex participation is of concern because it has the potential to 
transmit HIV to multiple individuals in rapid succession, and literature suggests that young 
adult group sex participants report elevated rates of HIV discordance and condomless sex 
(Friedman, Mateu-Gelabert, and Sandoval 2011, Friedman et al. 2008). Group sex events 
often include participants from multiple populations, including substance users, injection 
drug users, non-substance users, men who have sex with men, sex buyers or exchangers, and 
others; thus group sex events may also function as bridge environments allowing for HIV to 
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be transmitted to multiple populations (Friedman, Mateu-Gelabert, and Sandoval 2011, 
Friedman et al. 2008). Thus prescription opioid misusers may be engaging in sex with 
members of other high risk populations, potentially leading to greater vulnerability with 
regard to sexual HIV or hepatitis C transmission or infection.
Severe mental distress was also associated with alternate routes of administration in the 
multivariate model. This link is unsurprising given the literature documenting multiple 
mental health problems associated with prescription opioid misuse, including among young 
adult injection drug users (Mackesy-Amiti, Donenberg, and Ouellet 2015). However, mental 
health problems are also associated with HIV transmission risk among substance users 
(German and Latkin 2012). Therefore, the co-occurrence of risk factors for HIV and 
hepatitis C related to alternate routes of administration, group sex participation, and severe 
mental distress are especially worrisome.
Although not significant in the multivariate model, bivariate analyses also revealed several 
sexual HIV risk behaviors associated with alternate routes of administration, including 
engaging in sex with an injection drug user. Moreover, condomless anal intercourse and 
trading/selling sex were very nearly significantly associated with alternate routes of 
administration in the bivariate models. These practices are documented risk factors for 
sexual HIV infection among substance users (Ibañez et al. 2010, Celentano, Latimore, and 
Mehta 2008). Sexual victimization history, another HIV transmission risk factor, was also 
associated with alternate routes of administration. These risk factors may be exacerbated 
when combined with other behaviors associated with prescription opioid misuse, including 
risky injection practices and sex while high (Mateu-Gelabert et al. 2015, Jessell et al. 2015, 
Meade et al. 2014).
These findings have implications for sexual HIV risk reduction and prevention. First, 
previous research among young adult substance users suggests that administering 
comprehensive assessments of substance use, sexual behavior, and related health and social 
problems may have a strong intervention effect (Kurtz et al. 2013). Such comprehensive 
assessments may be useful in identifying prescription opioid dependent individuals who 
require additional clinical or sexual risk reduction intervention (Meade et al. 2014). In 
addition, risky injection practices and HIV and Hepatitis C transmission among prescription 
opioid misusers has been documented (Johnson et al. 2013, Lankenau et al. 2012, Surratt et 
al. 2011). Current findings suggest that sexual risk behavior, including group sex, is also an 
important HIV risk factor for this population (Mateu-Gelabert et al. 2015, Buttram and 
Kurtz 2015). Therefore, substance use prevention and intervention programs must address 
HIV transmission risks related to sexual and substance use behaviors among polysubstance-
using young adults and prescription opioid misusers.
Finally, several harm reduction strategies have been implemented to address the growing 
problem of prescription opioid misuse and alternate route of administration practices such as 
injection. Evidence demonstrates that needle and syringe exchange programs reduce 
injection risk behavior and prevent HIV and hepatitis C transmission (MacArthur et al. 
2014) and supervised injection facilities, although currently prohibited in the U.S., are linked 
to reductions in overdose mortality (Marshall et al. 2011). In addition, the use of medication-
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assisted treatment such as methadone and buprenorphine is associated with decreases in 
opioid use (Zaller, Yokell, Green, Gaggin and Case 2013). It has been argued that engaging 
young adults in harm reduction services must be a key element of the public health response 
to the prescription opioid epidemic (Marshall et al. 2016). Findings from the current study 
suggest that coupling sexual HIV risk reduction education and intervention with harm 
reduction services may have a greater impact on HIV and hepatitis C transmission among 
this population.
Limitations
Although recruitment procedures resulted in a sample broadly inclusive of the racial/ethnic 
makeup of Miami-Dade County, our ability to generalize the findings to other young adult 
club drug users and/or prescription opioid misusers who report alternate routes of 
administration is limited by the study eligibility requirements. Furthermore, all data are 
based on self-report, potentially leading to underreporting of socially undesirable behaviors. 
Given the high levels of substance use and sexual risk behaviors we found, however, 
underreporting of these and other stigmatized behaviors would appear to be uncommon.
Conclusions
The present study contributes to the literature on alternate routes of administration of 
prescription opioids by specifically examining health and social problems which may be 
influencing factors in sexual HIV transmission. Early prevention and intervention efforts that 
address both sexual and non-sexual HIV and hepatitis C transmission are needed among 
polysubstance-using young adults. Data suggest that young adult prescription opioid 
misusers develop riskier drug use and sexual networks as their drug use progresses (Mateu-
Gelabert et al. 2015). As a result, early intervention, including comprehensive assessments 
of substance use and sexual behaviors, and a focus on sexual HIV transmission risks, 
including group sex, may be warranted.
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 Age 25.14 (5.395)
N %
Demographics and Background
 Hispanic 286 64.1%
 African American/Black 97 21.7%
 White 50 11.2%
 Other race/ethnicity 13 2.9%
 Female 202 45.3%
 Education ≥ 12 years 379 85.0%
Past 90 day Substance Use
 Alcohol 445 99.8%
 Marijuana 425 95.3%
 Cocaine 418 93.7%
 Ecstasy 438 98.2%
 Crack cocaine 127 28.5%
 LSD 224 50.2%
 Hallucinogens 260 58.3%
 Methamphetamine 114 25.6%
 GHB 77 17.3%
 Heroin 103 23.1%
 Rx stimulants 222 49.8%
 Rx sedatives 417 93.5%
 Rx antidepressants 120 26.9%
 Rx antipsychotics 132 29.6%
 Injection drug use 66 14.8%
 Alternate route of administration 157 35.2%
Sexual HIV Transmission Risk Behavior
 Condomless vaginal sexa 404 90.6%
 Condomless anal sexa 179 40.1%
 Group sex participation history 183 41.0%
 Buy sexb 49 11.0%
 Trade/sell sexb 64 14.3%
 Sex with IDUb 56 12.6%
 High risk sexa 308 69.1%
 High for sex ≥ half the timea 350 78.5%
Health and Social Problems
 Physical abuse history 193 43.3%
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M (SD)
 Sexual abuse history 85 19.1%
 Severe mental distressb 232 52.0%
 Substance dependencea 261 58.5%
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Table 2
Bivariate logistic regression models of administration among prescription opioid misusers (N=446)
p OR 95% CI
Demographics
 Younger age (18–24) 0.932 0.983 0.666, 1.451
 Female 0.070 0.695 0.468, 1.030
 Race/ethnicitya
  Hispanic 0.001 0.364 0.197, 0.674
  African American/Black 0.000 0.207 0.099, 0.432
  Other race/ethnicity 0.025 0.200 0.049, 0.818
Sexual HIV Transmission Risk Behavior
 Condomless vaginal intercourseb 0.202 1.595 0.778, 3.267
 Condomless anal intercourseb 0.054 0.579 0.331, 1.010
 Group sex participation history 0.002 1.876 1.264, 2.784
 Buy sexc 0.692 0.880 0.468, 1.655
 Trade or sell sexc 0.069 1.644 0.962, 2.810
 Sex with IDU 0.003 2.389 1.356, 4.209
 High risk sexb 0.443 1.181 0.772, 1.806
 High for sex ≥ half the timeb 0.178 1.350 0.872, 2.091
Health and Social Problems
 Physical abuse history 0.540 1.130 0.764, 1.672
 Sexual victimization history 0.003 2.089 1.294, 3.375
 Severe mental distressb 0.000 2.087 1.400, 3.111
 Substance dependencec 0.067 1.454 0.974, 2.170
 Arrest history 0.376 1.204 0.798, 1.816
a
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Table 3
Multivariate logistic regression models of alternate routes of administration among prescription opioid 
misusers (N=446)
p OR 95% CI
Race/ethnicitya
 Hispanic 0.003 0.378 0.198, 0.722
 African American/Black 0.000 0.211 0.098, 0.454
 Other race/ethnicity 0.015 0.161 0.037, 0.699
Group sex participation history 0.021 1.641 1.076, 2.503
Sex with IDUb 0.121 1.615 0.881, 2.962
Sexual abuse history 0.082 1.600 0.942, 2.717
Severe mental distressb 0.009 1.799 1.161, 2.789
a
Reference category is White
b
Past 12 months
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